GMED - Company ID 0001237831
The table below shows GLOBUS MEDICAL INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $759.85M | $769.05M | $745.34M | $598.12M | $625.71M | $629.69M |
| Cost of revenue | $234.07M | $252.53M | $248.76M | $195.40M | $270.51M | $260.04M |
| Gross profit | - | - | - | - | - | $369.65M |
| R&D | $36.51M | $38.07M | $39.95M | $33.06M | $35.38M | $37.70M |
GLOBUS MEDICAL INC reported annual revenue of $2.94B for fiscal year 2025. That is up 16.7% from $2.52B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $563.99M (FY 2016) to $2.94B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $297.77M | $313.60M | $303.62M | $242.80M | $240.06M | $239.45M |
| Operating income | $150.39M | $137.36M | $76.11M | $97.00M | $48.10M | $49.62M |
| Income tax | $32.77M | $25.03M | -$14.67M | $28.21M | $5.20M | $15.82M |
| Net income | $124.30M | $118.97M | $202.85M | $75.46M | $51.84M | $31.76M |
| EPS (diluted) | $0.90 | $0.88 | $1.49 | $0.54 | $0.38 | $0.23 |